{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/cholecystitis-acute/management/management/","result":{"pageContext":{"chapter":{"id":"ae1135d3-c461-5abc-87a0-4e63b4e6e95b","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 77a86482-a7f6-405b-9c7d-f2ea6810374e --><h2>Scenario: Management</h2><!-- end field 77a86482-a7f6-405b-9c7d-f2ea6810374e -->","summary":"Covers the primary care management of people with acute cholecystitis.","htmlStringContent":"<!-- begin item 2d0a3063-ab84-4356-9f9f-e9751101120f --><!-- begin field 5e35202c-d7c0-4aa0-84c7-acbc0156819e --><p>From age 18 years onwards.</p><!-- end field 5e35202c-d7c0-4aa0-84c7-acbc0156819e --><!-- end item 2d0a3063-ab84-4356-9f9f-e9751101120f -->","topic":{"id":"586b9043-cd4f-500b-9011-7dd73a611591","topicId":"9a35e260-b6dc-4b03-8b00-5d3422419371","topicName":"Cholecystitis - acute","slug":"cholecystitis-acute","lastRevised":"Last revised in January 2017","chapters":[{"id":"126ce66c-8a30-5c27-8c22-83fac4025f12","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"79501bdc-34cc-5a87-a36e-683848b4c91d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9e1b6041-fffc-5640-8cc1-19dba199c9a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b7b40268-5afd-59e9-bd11-b1780b1dcdf1","slug":"changes","fullItemName":"Changes"},{"id":"c423c6c2-4a3d-5739-a021-d6922a5391eb","slug":"update","fullItemName":"Update"}]},{"id":"4184a3d3-71fb-52af-8656-1179a4d0345a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5feb667a-2aeb-5a10-a6d3-e84c58e4fa7f","slug":"goals","fullItemName":"Goals"},{"id":"3a5f160d-975e-566e-a944-06dad6ab35eb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a550cc5e-72ae-5710-9362-89519a5b930a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b3471362-958c-5e95-ba0e-0050a948933d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"95581b93-95cb-5a6b-959e-0a46a0c77c5e","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"700e5513-d44c-56af-b6e3-677455d7cee6","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"707f1664-1735-5d4c-b128-207bd90fc3d2","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9a710019-f680-5d56-8337-dc48db5e3e1c","slug":"definition","fullItemName":"Definition"},{"id":"9269add6-b94d-5d31-acfa-484765e3335d","slug":"causes","fullItemName":"Causes"},{"id":"341a19fc-6ddf-5074-b8a0-94265202c787","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"1df8e6b3-6718-54c8-88a0-2be4f049b372","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e4b0d686-4dd0-536c-b865-d6b6f318477c","slug":"complications","fullItemName":"Complications"}]},{"id":"2e78144c-0929-5a88-b151-365b00140b75","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d94b0daf-64dc-59ba-878d-51e403f36e45","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"dfc7867d-7577-5113-a6c8-45c5c26ce8dd","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"ab490765-80b8-5a98-a520-f9dd88fb8998","fullItemName":"Management","slug":"management","subChapters":[{"id":"ae1135d3-c461-5abc-87a0-4e63b4e6e95b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"d6c47b17-660a-53da-8949-76f5f8d93f0b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f59d51a8-efe1-58c5-88b9-5afb1c55c638","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8e1398a1-d032-53c3-9305-6f3d6c90bebf","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"e5b649dd-0ece-5c4f-a976-702adc5189c3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"182e67d0-bde6-5b1e-bcd4-201cd58a7795","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"1b83582f-708c-51b9-b2c7-75df15a121bf","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"70884d09-80b4-51dc-9da5-896c37eeec00","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b83eadf0-24d3-5adb-81ae-17b9a86653d7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ab490765-80b8-5a98-a520-f9dd88fb8998","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1ecdc36e-e497-5bde-9474-ad6651c65321","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 06227fe7-7a0a-4186-9c59-bb98e0983059 --><h3>Management</h3><!-- end field 06227fe7-7a0a-4186-9c59-bb98e0983059 -->","summary":null,"htmlStringContent":"<!-- begin item 01e33a93-e5e0-4ec7-bc10-823c92b803dc --><!-- begin field 91f6785f-20ca-453e-9f20-75b6774f6015 --><ul><li>Urgently admit to hospital anyone with suspected acute cholecystitis for:<ul><li>Confirmation of the diagnosis (including abdominal ultrasound, and blood tests such as a white blood cell count, C-reactive protein, and serum amylase).</li><li>Monitoring (for example blood pressure, pulse, and urinary output).</li><li>Treatment (may include intravenous fluids, antibiotics, and analgesia).</li><li>Surgical assessment for cholecystectomy.</li></ul></li></ul><!-- end field 91f6785f-20ca-453e-9f20-75b6774f6015 --><!-- end item 01e33a93-e5e0-4ec7-bc10-823c92b803dc -->","subChapters":[{"id":"fc54699d-fc2d-543c-be92-1f3d40d6b65f","slug":"basis-for-recommendation-e9d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7aefaced-5282-4c25-95ce-efbe7c7e8da6 --><h4>Basis for recommendation</h4><!-- end field 7aefaced-5282-4c25-95ce-efbe7c7e8da6 -->","summary":null,"htmlStringContent":"<!-- begin item e9df1717-ba00-4069-83c3-85963067973d --><!-- begin field 838dcd05-5f7c-468f-9b50-9aaf52f73f7d --><h5>Admission to hospital</h5><ul><li>The Royal College of Surgeons' <em>Commissioning guidance: gallstone disease</em> states that if acute cholecystitis is suspected the person should be referred to hospital as an emergency [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Royal College of Surgeons, 2016</a>]. Urgent admission to secondary care is recommended because of the high mortality rate (up to 10%) associated with acute cholecystitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Kimura et al, 2013</a>].</li></ul><p><strong>Confirmation of the diagnosis</strong> (including abdominal ultrasound, and blood tests such as a white blood cell count, C-reactive protein, and serum amylase).</p><ul><li><p>Guidelines from international panels of experts [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Ansaloni et al, 2016</a>] discuss that there is no single test to diagnose or exclude acute cholecystitis, but the diagnosis takes into account history, examination findings, and test results. </p><ul><li><p>Measuring a white cell count and C-reactive protein level can confirm an inflammatory response. Other blood tests including platelet count, measurement of renal and liver function (may show raised bilirubin alkaline phosphatase, and gamma-GT), and clotting can help to assess severity of illness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">BMJ Best Practice, 2016</a>]. These tests are not usually performed in primary care because of the need for urgent referral to secondary care. </p></li></ul></li><li><p>Guidelines from international panels of experts recommend abdominal ultrasound for every person with suspected acute cholecystitis because of its accuracy for detecting gallbladder stones and its availability, cost, and lack of invasiveness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Ansaloni et al, 2016</a>].</p><ul><li><p>In acute cholecystitis the gallbladder is typically enlarged with a thickened wall, containing stones or debris, in the presence of a sonographic Murphy's sign [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">BMJ Best Practice, 2016</a>] (pain worsens on pressure of the probe over the gallbladder) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">European Association for the Study of the Liver, 2016</a>]. There may also be pericholecystic fluid or abscess [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>].</p></li></ul></li><li><p>An abdominal CT scan with intravenous contrast may be useful in the evaluation of acute biliary tract disease as it can show gallbladder distension, wall thickening, and complications such as abscess and perforation. It can be useful if ultrasound findings are limited by gaseous distension or obesity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">BMJ Best Practice, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">European Association for the Study of the Liver, 2016</a>].</p></li><li><p>Other investigations which may be used in secondary care in the assessment of acute cholecystitis include radioisotope cholescintigraphy (Tc-HIDA scan) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">European Association for the Study of the Liver, 2016</a>].</p></li></ul><p><strong>Monitoring</strong> (for example blood pressure, pulse, and urinary output).</p><ul><li>A guideline from an international panel of experts recommends monitoring the respiratory and haemodynamic state of a person with acute cholecystitis in preparation for emergency surgery [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>].</li><li>This information is also consistent with a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">BMJ Best Practice, 2016</a>].</li></ul><p><strong>Treatment</strong> (may include intravenous fluids, antibiotics, and analgesia).</p><ul><li>This is consistent with recommendations from the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland to admit people with acute cholecystitis to hospital for fluid resuscitation, antibiotics, and analgesia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, 2015</a>] and is also supported by a guideline from an international panel of experts [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Miura et al, 2013</a>] and a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">BMJ Best Practice, 2016</a>]. </li></ul><p><strong>Surgery</strong></p><ul><li>Cholecystectomy is the surgical treatment of choice for acute calculous cholecystitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">Ansaloni et al, 2016</a>] — gallbladder inflammation often persists despite medical therapy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">BMJ Best Practice, 2016</a>].</li><li>The National Institute for Health and Care Excellence guideline <em>Gallstone disease: diagnosis and management </em>recommends early laparoscopic cholecystectomy (to be carried out within 1 week of diagnosis) for people with acute cholecystitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/cholecystitis-acute/references/\">NICE, 2014</a>]. </li></ul><!-- end field 838dcd05-5f7c-468f-9b50-9aaf52f73f7d --><!-- end item e9df1717-ba00-4069-83c3-85963067973d -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}